toxic epidermal necrolysis

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Toxic Epidermal Necrolysis Trial in Fuzhou (Abrocitinib)

Recruiting
  • Toxic Epidermal Necrolysis
  • Fuzhou, Fujian, China
    Department of Dermatology, the First Affiliated Hospital of Fuji
Oct 31, 2023

Epidermal Necrolysis, Lyell Syndrome, Toxic Epidermal Necrolysis Trial (Adipose derived stromal cells intravenously injected)

Not yet recruiting
  • Epidermal Necrolysis
  • +5 more
  • Adipose derived stromal cells intravenously injected
  • (no location specified)
Sep 27, 2021

Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis

Unknown status
  • Stevens-Johnson Syndrome
  • +2 more
  • Site specific standard of care comparison
  • (no location specified)
Dec 1, 2020

Toxic Epidermal Necrolysis Trial in Sacramento (Clobetasol 0.05% ointment, Placebo)

Withdrawn
  • Toxic Epidermal Necrolysis
  • Clobetasol 0.05% ointment
  • Placebo
  • Sacramento, California
    University of California, Davis Department of Dermatology
Aug 7, 2019

Steven-Johnson Syndrome, Toxic Epidermal Necrolysis, Drug Reaction With Eosinophilia and Systemic Symptoms Trial in Bangkok

Unknown status
  • Steven-Johnson Syndrome
  • +4 more
    • Bangkok, Thailand
      Faculty of Medicine, Chulalongkorn University
    Feb 15, 2019

    Toxic Epidermal Necrolysis Trial in Boston (Isotretinoin, Placebo)

    Unknown status
    • Toxic Epidermal Necrolysis
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 5, 2016

    Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome Trial in Bridgeport, New Haven (Palifermin)

    Terminated
    • Toxic Epidermal Necrolysis
    • Stevens-Johnson Syndrome
    • Bridgeport, Connecticut
    • +1 more
    Oct 6, 2016

    Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis Trial in Tokyo (Intravenous immunoglobulin)

    Completed
    • Stevens-Johnson Syndrome
    • Toxic Epidermal Necrolysis
    • Intravenous immunoglobulin
    • Tokyo, Japan
      Nihon Pharmaceutical Co., Ltd
    Jul 1, 2014

    Toxic Epidermal Necrolysis Trial (Remicaide (infliximab))

    Withdrawn
    • Toxic Epidermal Necrolysis
    • Remicaide (infliximab)
    • (no location specified)
    Apr 25, 2013